Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sustained-release dextropropoxyphene.].

K Kurz-Müller1, M Zenz

  • 1Intensiv- und Schmerztherapie Berufsgenossenschaftliche Krankenanstalten Bergmannsheil Bochum, Universitätsklinik für Anästhesiologie, Gilsingstr. 14, W-4630, Bochum 1.

Schmerz (Berlin, Germany)
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Withholding life-sustaining therapies-interdisciplinary responsibility].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

[The responsibilities of reviewers and editors].

Schmerz (Berlin, Germany)·2017
Same author

Post-traumatic pain. Causes and therapeutic concepts.

Der Orthopade·2017
Same author

[Chronic pain in general practice : Results from pain specialists].

Schmerz (Berlin, Germany)·2017
Same author

[What is the point of this study?].

Schmerz (Berlin, Germany)·2015
Same author

[Euthanasia and physician-assisted suicide : Attitudes of physicians and nurses].

Schmerz (Berlin, Germany)·2015
Same journal

Schmerz (Berlin, Germany)·2026
Same journal

Schmerz (Berlin, Germany)·2026
Same journal

Schmerz (Berlin, Germany)·2026
Same journal

[Postoperative pain and sex/gender-current findings of the past decade].

Schmerz (Berlin, Germany)·2026
Same journal

[Non-invasive neuromodulation for chronic pain : A review of eight current methods and the evidence].

Schmerz (Berlin, Germany)·2026
Same journal

[Pain medicine aspects of the updated S2k guideline "Diagnosis and treatment of endometriosis"].

Schmerz (Berlin, Germany)·2026
See all related articles

Dextropropoxyphene offers effective pain relief comparable to aspirin and paracetamol, with a lower addiction risk than codeine. Sustained-release dextropropoxyphene provides long-lasting analgesia for chronic pain management.

Area of Science:

  • Pharmacology
  • Pain Management
  • Drug Development

Context:

  • Dextropropoxyphene is a mild opioid analgesic.
  • It serves as a therapeutic alternative to other weak opioids like codeine.
  • It can replace or supplement non-steroidal anti-inflammatory agents.

Purpose:

  • To evaluate dextropropoxyphene as a pain management option.
  • To compare its efficacy and safety profile with other analgesics.
  • To highlight the benefits of sustained-release formulations.

Summary:

  • Dextropropoxyphene provides analgesia comparable to aspirin and paracetamol, with a lower addiction potential than codeine.
  • Sustained-release dextropropoxyphene offers 8-12 hour pain relief for chronic pain, with minimal risk of cumulation or overdosage.

Related Experiment Videos

  • It is a viable option for the second stage of the WHO analgesic ladder.

    • Impact:

    • Provides a safer alternative for chronic pain management.
    • Improves patient independence through oral, sustained-release administration.
    • Reduces the risk of adverse events associated with other analgesics.